Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions. - Wikidata - wikimedia - TriplyDB

Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.

Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.

http://www.wikidata.org/entity/Q33782620

about

Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review Molecular pathogenesis of pulmonary arterial hypertension Macrophages and Their Role in Atherosclerosis: Pathophysiology and Transcriptome Analysis Endogenous Generation and Signaling Actions of Omega-3 Fatty Acid Electrophilic Derivatives Redox implications in adipose tissue (dys)function--A new look at old acquaintances New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease Interplay between oxidant species and energy metabolism Protection from hypertension in mice by the Mediterranean diet is mediated by nitro fatty acid inhibition of soluble epoxide hydrolase Oxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signaling The Chemical Basis of Thiol Addition to Nitro-conjugated Linoleic Acid, a Protective Cell-signaling Lipid Phenotypic modulation of macrophages in response to plaque lipids.Nitro-fatty acids and cyclopentenone prostaglandins share strategies to activate the Keap1-Nrf2 system: a study using green fluorescent protein transgenic zebrafish Electrophilic fatty acid species inhibit 5-lipoxygenase and attenuate sepsis-induced pulmonary inflammation.Nitro-Oleic Acid Prevents Hypoxia- and Asymmetric Dimethylarginine-Induced Pulmonary Endothelial Dysfunction.Protective effects of 10-nitro-oleic acid in a hypoxia-induced murine model of pulmonary hypertension Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice Endogenous ligands for nuclear receptors: digging deeper.15-Oxoeicosatetraenoic acid is a 15-hydroxyprostaglandin dehydrogenase-derived electrophilic mediator of inflammatory signaling pathways.Inhibition of Mycobacterium tuberculosis PknG by non-catalytic rubredoxin domain specific modification: reaction of an electrophilic nitro-fatty acid with the Fe-S center Electrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism.Electrophilic fatty acids regulate matrix metalloproteinase activity and expression.15-Hydroxyprostaglandin dehydrogenase generation of electrophilic lipid signaling mediators from hydroxy ω-3 fatty acids.Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival Nitroalkene fatty acids mediate activation of Nrf2/ARE-dependent and PPARγ-dependent transcription by distinct signaling pathways and with significantly different potencies.Nitrooleic acid protects against cisplatin nephropathy: role of COX-2/mPGES-1/PGE2 cascade.Oxidative stress, redox regulation and diseases of cellular differentiation.Nitrostyrene Derivatives Act as RXRα Ligands to Inhibit TNFα Activation of NF-κB.Cell signalling by reactive lipid species: new concepts and molecular mechanisms.Formation and signaling actions of electrophilic lipids Nitric oxide in liver diseases.Conjugated linoleic acid is a preferential substrate for fatty acid nitration.Nitro-fatty acids in cardiovascular regulation and diseases: characteristics and molecular mechanisms.Nitro-oleic acid modulates classical and regulatory activation of macrophages and their involvement in pro-fibrotic responses.Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts.Protection of nitro-fatty acid against kidney diseases.Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine.Thioredoxin reductase 1 suppresses adipocyte differentiation and insulin responsiveness Modulation of nitro-fatty acid signaling: prostaglandin reductase-1 is a nitroalkene reductase Combined losartan and nitro-oleic acid remarkably improves diabetic nephropathy in mice.Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans.

P2860

Q24561401-1BC72D71-C260-4CAD-98DA-772D515F03F4 Q24634317-D9ED2169-263A-40F7-B652-FC69122E6D9F Q26738772-587457A3-E9A8-4B68-A0AF-125CE056A514 Q26784513-33A8402B-C111-42E7-9327-ECBF23E9E6E6 Q26801347-1B622699-D5A3-4206-806C-05B306B187E1 Q26851490-02DED5EA-FA57-44B8-8D42-79AD835377E6 Q28383905-B94E56A3-FA59-49DC-914B-9EEEE05BDC26 Q28387540-4E608188-6D75-4CE2-82C0-82ADF1018F1B Q28393242-92CF2AEC-D96A-4906-ABF8-A80CFAA5A254 Q28818086-10E3776F-22DF-4B74-8796-6EE41652A5BC Q30413906-31D407A4-91C6-4889-8F8B-AC1D637632AC Q30586026-9CD4ADF5-426D-4D6D-9AF0-1918CBCBE02F Q33632763-DCDD36EC-146A-46B6-BAAA-599B66A34CE2 Q33850620-9A0ECB4C-392D-4D9F-A474-911A5CA38B95 Q33881508-E7ACE359-1EC3-4F54-9CD9-D3215C91C70D Q34199764-0C1D02BA-9C82-414A-B0A4-A402A13AAD4B Q34412495-567F2D52-71D3-42F9-8CC0-F2003666A846 Q34450882-E2807AC8-09D5-4C20-975E-63B07378099A Q34781265-87F1C412-AAFB-4F8C-B4CC-3C8F18DD24D2 Q34800018-256FBAF2-3F27-44BB-AABF-DF47D56FBAA0 Q34963415-FC86BE20-5023-4B5C-9604-89F2B8025847 Q35126717-941582DB-F0D5-4A06-A23F-759ED4E11CD5 Q35187029-8005D82E-2E5D-4AB6-B6E8-5D8AF2D29072 Q35201387-B4991224-869F-47B0-B038-F81F78FEC94F Q35227002-0D2DCEA7-ACD9-4FD6-9A55-A879F2EAE7B9 Q35611511-86F5CAAA-1A98-471F-B45E-B45B11E5AAA1 Q35612396-3C34FC05-EB4C-4F51-BFEA-9E32F2795512 Q35778758-C45BE7B0-60DF-481D-AEC5-6F183A043704 Q35804051-BCD5FA40-5188-4E13-A23C-34A1BBC2B06E Q35940869-830E9B2B-81B3-4078-9B11-A8B161181A00 Q36492744-59C9D1E4-C93C-4DB9-BD16-C5200A5117E2 Q36565424-B021B859-DC10-4F7D-B349-038601A7E3E4 Q36567097-072B8BBA-4551-47BC-9E2D-0CC3CB94BFE3 Q36687046-A7F2A555-5A5A-4CEE-8965-54461C47D733 Q36810720-61FE8F2C-9E69-4DD5-BE73-5B118AF8FEDE Q36920628-AE36D728-33EB-4238-BD1D-74F5222C7FD7 Q37039957-A32DB6B7-3FAC-4EF6-BD20-AEF5D6713C8F Q37132192-710A370B-7A39-42FE-B564-CF32DA56F1D0 Q37439729-054BE72C-B42A-4FC4-BF90-A804310D1D57 Q37560854-2394E593-BB99-4E87-89E1-A38EE48528B0

P2860

Covalent peroxisome proliferator-activated receptor gamma adduction by nitro-fatty acids: selective ligand activity and anti-diabetic signaling actions.

http://www.wikidata.org/entity/Q33782620

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Covalent peroxisome proliferat ...... ti-diabetic signaling actions.

@ast

Covalent peroxisome proliferat ...... ti-diabetic signaling actions.

@en

type

label

Covalent peroxisome proliferat ...... ti-diabetic signaling actions.

@ast

Covalent peroxisome proliferat ...... ti-diabetic signaling actions.

@en

prefLabel

Covalent peroxisome proliferat ...... ti-diabetic signaling actions.

@ast

Covalent peroxisome proliferat ...... ti-diabetic signaling actions.

@en

P1433

Q33782620-F9287521-4654-4DE6-AE8E-C13E0111775C

P1476

Q33782620-9EAF8BA7-6AE6-4350-ABB1-E1FEF76BC86F

P2093

Q33782620-196AC479-1E46-4397-A505-B278D44BD3C3

Q33782620-2A15B4F2-64A2-44AE-BA2C-4DD87E114C71

Q33782620-47618CB4-0B27-4413-99BA-6F3CC8A4D759

Q33782620-54E455CF-88D0-47CE-8532-00C6C6F3EEFC

Q33782620-61783BAD-7C72-4206-8AA8-234E29B86B0B

Q33782620-632286FC-E126-48D2-9E84-EA9DE9D615D8

Q33782620-66417D84-B220-46D3-BD0D-C1CDCE085066

Q33782620-84E0AFAD-BEEB-456F-82CD-7BE418A22A03

Q33782620-891BB944-2843-49C2-B97A-6D053D21B439

Q33782620-8B44128C-5327-4AB7-A5F1-C424BD7F79D0

P2860

Q33782620-01313C27-0BAD-4CB6-BFDB-A9B548D71D4B

Q33782620-0D9E4B73-7CFA-42C2-ADB2-C30C5ADA9E53

Q33782620-10DFA7AC-A216-48A0-8284-60BC66369103

Q33782620-18AFAC16-B828-4F62-9A0B-9B081FC65910

Q33782620-1F04D277-BF79-408C-B80D-B35A354F8994

Q33782620-25DECBDF-FC7F-402C-8DB1-05AB7B6CA0FF

Q33782620-2E24344B-C476-4753-AC84-F7611AF3DE33

Q33782620-3662B631-CD27-4CB8-8AB7-6956737B82DE

Q33782620-37CB3702-8B35-4E3F-A9EF-5061AD6C7F19

Q33782620-3C407E9C-E8AE-4F59-AEC4-07021D3D4C62

P304

Q33782620-4E340EC3-3A80-4130-975E-3AC627E9E429

P31

Q33782620-16586E08-0183-4A26-9CB2-4405BC273630

P356

Q33782620-0971F23B-9067-48F6-9546-BD5F36EEDE60

P407

Q33782620-3CA947E6-A2D5-48EA-95E4-5D769BAEB112

P433

Q33782620-5587AB46-459A-4774-AAE4-302269A05796

P478

Q33782620-94A54C94-8A5E-4C84-8CC9-2693C08F2037

P577

Q33782620-90FC34C4-CF33-40FB-BB73-92F6B608A30C

P698

Q33782620-FED70F4F-E3F1-4F44-8EDB-CA67A782F950

P921

Q33782620-F2E1F7A1-F3CD-4E8C-AAB5-FF5216DF4837

P932

Q33782620-FA97F8A4-FDA6-4E93-8F54-0A67EC334352

P356

JBC.M109.091512

P1433

Journal of Biological Chemistry

P1476

Covalent peroxisome proliferat ...... ti-diabetic signaling actions.

@en

P2093

Alison L Groeger

http://www.w3.org/2001/XMLSchema#string

Bruce A Freeman

http://www.w3.org/2001/XMLSchema#string

Carlos I Batthyany

http://www.w3.org/2001/XMLSchema#string

Chen-Shan Chen

http://www.w3.org/2001/XMLSchema#string

Franca Golin-Bisello

http://www.w3.org/2001/XMLSchema#string

Francisco J Schopfer

http://www.w3.org/2001/XMLSchema#string

Gustavo Bonacci

http://www.w3.org/2001/XMLSchema#string

H Eric Xu

http://www.w3.org/2001/XMLSchema#string

Jifeng Zhang

http://www.w3.org/2001/XMLSchema#string

Marsha P Cole

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

T2384, a novel antidiabetic agent with unique peroxisome proliferator-activated receptor gamma binding properties

Molecular recognition of nitrated fatty acids by PPARγ

Structural insight into PPARgamma activation through covalent modification with endogenous fatty acids

Structural basis for the activation of PPARgamma by oxidized fatty acids

Fat and beyond: the diverse biology of PPARgamma

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators

P304

12321-12333

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M109.091512

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20097754

http://www.w3.org/2001/XMLSchema#string

P921

P932

2852971

http://www.w3.org/2001/XMLSchema#string